Repurposed drug may be first targeted treatment for serious kidney disease

(Massachusetts General Hospital) A team led by Massachusetts General Hospital researchers is reporting that treatment with abatacept appeared to halt the course of focal segmental glomerulosclerosis in five patients, preventing four from losing transplanted kidneys and achieving disease remission in the fifth.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news